Non-invasive mucosal vaccine delivery: advantages, challenges and the future

Mariusz Skwarczynski,Istvan Toth
DOI: https://doi.org/10.1080/17425247.2020.1731468
2020-02-26
Expert Opinion on Drug Delivery
Abstract:The vast majority of vaccines are designed to protect us against infectious diseases; the majority of these diseases are caused by pathogens entering our body via mucosal routes. Therefore, it could logically be expected that the majority of vaccines would be delivered through mucosal routes and work by mimicking natural infection. However, the fact that this is not the case presents an interesting question of why this is so; should we be trying to go down this path in the future; and if so, what is necessary to achieve this immunization strategy?
pharmacology & pharmacy
What problem does this paper attempt to address?